ライフサイエンスコーパス: biopsy

1 ith positive results from in-bore MRI-guided biopsy).

2 (ATN) and normal kidney (baseline transplant biopsies).

3 81 true-positive findings of 419 core-needle biopsies).

4 nts underwent (68)Ga-PSMA PET/CT before bone biopsy.

5 red RAD51 foci formation on end of treatment biopsy.

6 a serology, pericardial effusion analysis or biopsy.

7 th in DNA and mRNA extracted from each tumor biopsy.

8 CT-guided biopsy and 125 underwent CT-guided biopsy.

9 collection to investigate STIs and for anal biopsy.

10 s, followed by high-resolution anoscopy with biopsy.

11 avenue for cancer monitoring based on liquid biopsy.

12 tients with borderline/TCMR 1A identified on biopsy.

13 and the ability to visualize lesions during biopsy.

14 leason score in patients undergoing prostate biopsy.

15 RI may play a role as a replacement test for biopsy.

16 evolving mutations as a surrogate for tumour biopsy.

17 participants undergoing a transjugular liver biopsy.

18 showed a stable renal function at the day of biopsy.

19 id tissue in the patient's thymus transplant biopsy.

20 ually on histological examination from liver biopsy.

21 units) were strong predictors for a positive biopsy.

22 o association with upgrading in surveillance biopsy.

23 has been provided through tissue and liquid biopsy.

24 f the same muscle with repeat MRI and muscle biopsy.

25 rome (NS) was the most common indication for biopsy.

26 surgical resection, and enable image-guided biopsy.

27 he dominant lesion in 93% of the 60 patients biopsied.

28 cle and WNT signaling pathways in responding biopsies.

29 p neural networks for assessment of prostate biopsies.

30 toms of gastritis, routinely undergo gastric biopsies.

31 ion of the triradylglycerol content in liver biopsies.

32 r gamma rearrangement present in the gastric biopsies.

33 ed with collagen deposition in endobronchial biopsies.

34 reast abnormalities and reducing unnecessary biopsies.

35 At liver biopsy 1, mean %HCV-infected cells = 25.2% (95% confiden

36 CBCT with XperGuide software was used to biopsy 100 nodules, and CCT guidance was used to biopsy

37 th MRI-targeted biopsy (8.7%) and systematic biopsy (16.8%).

38 RNA (Spearman rank correlation r = 0.9); at biopsy 2 (Day 7 in 4 of 5 participants), mean %HCV-infec

39 sy 100 nodules, and CCT guidance was used to biopsy 266 nodules.

40 patients, the majority underwent excisional biopsy (55.3%, n = 302/546) or lumpectomy (wide excision

41 Twenty patients underwent a pretreatment biopsy, 6 months of once per day oral talazoparib (1 mg)

42 cimens (3.5%), as compared with MRI-targeted biopsy (8.7%) and systematic biopsy (16.8%).

43 NS was the most common indication for biopsy across all age groups and genders.

44 on imaging yielded alternative diagnoses on biopsy, adding support for pathology-proven data to guid

45 female; mean age, 49.5 +/- 13.1 y old) were biopsied after the detection of a dnDSA, 65.3 months (me

46 gut mucosal microbiome composition, mucosal biopsies allowed detecting the subtle variations of loca

47 Liquid biopsy analysis of circulating cell-free DNA fragments i

48 iagnoses of celiac disease based on duodenal biopsy analysis.

49 constituting 89.9% (578 of 643) of DM-guided biopsies and 71.1% (542 of 762) of DBT-guided biopsies (

50 An increasing volume of prostate biopsies and a worldwide shortage of urological patholog

51 Low numbers of L cells in intestinal biopsies and high serum levels of GLP-2 were associated

52 Genetic sequences from 320 MSI tumor biopsies and matched healthy tissues in The Cancer Genom

53 n kidney transplantation (KT) using protocol biopsies and noninvasive biomarkers has not been evaluat

54 Reducing unnecessary biopsies and rapid characterization of breast microcalci

55 f whom 216 underwent (18)F-FDG PET/CT-guided biopsy and 125 underwent CT-guided biopsy.

56 The combined use of SN biopsy and PSMA PET/CT identified all pN1 patients (100%

57 y status, and grade reclassification between biopsy and radical prostatectomy.

58 ound healing and discuss how wounding, as in biopsy and surgery, might positively or negatively influ

59 sis, and suggestions for transbronchial lung biopsy and surgical lung biopsy were also made.

60 E diagnosis was confirmed by a positive skin biopsy and/or genetic testing.

61 y a combination of the two methods (combined biopsy), and 404 (19.2%) underwent radical prostatectomy

62 oor DCE perfusion MRI quality, nondiagnostic biopsy, and extensive spinal metastasis or prior kyphopl

63 imb magnetic resonance imaging (MRI), muscle biopsy, and genetic testing.

64 e negative for cancer; one patient underwent biopsy, and the result was positive for cancer; and 264

65 normal cytology were referred to colposcopy, biopsy, and treatment as needed.

66 There is substantial interest in liquid biopsy approaches for cancer early detection among subje

67 tecting dietary transgressions, and duodenal biopsies are invasive, expensive, and not a routine moni

68 es with contrast administration and/or liver biopsy are mostly necessary for establishing diagnosis,

69 kocyte subsets were assessed in nasal mucosa biopsies at baseline and after treatment.

70 refer high-risk patients to specialists for biopsy-based diagnosis.

71 23/24 (96%) of the respondents took a biopsy before surgery.

72 ospitalized patients undergoing native renal biopsy between January 1, 2009 and December 31, 2018.

73 s who underwent DCE perfusion MRI and lesion biopsy between May 2015 and May 2018 were included.

74 ive, multi-omics approaches since the kidney biopsy, blood and urine samples used to generate these d

75 Interposing MBI reduced the number of biopsies by 67.5%.

76 re examined in the sera by ELISA and in skin biopsies by immunohistochemistry and in situ RNA hybridi

77 In adipose tissue biopsies, changes in fibrosis were evaluated by immunohi

78 A kidney biopsy confirmed the diagnosis of kappa AL amyloidosis.

79 The primary endpoint was biopsy-confirmed acute rejection (BCAR) within 60 weeks

80 e performed endoscopy in 80 children who had biopsy-confirmed EED and available plasma and duodenal s

81 and 69 MRI examinations, and 67% of them had biopsy-confirmed metastases.

82 ological efficacy of NGM282 in patients with biopsy-confirmed nonalcoholic steatohepatitis.

83 ysed in patients aged 18 years or older with biopsy-confirmed pancreatic cancer of any stage, enrolle

84 IRI(+) prereperfusion biopsies contained macrophages with hyperacetylated, lys

85 We used real-world data from a large biopsy-controlled study of excessive drinkers recruited

86 ry, the regenerative response in FSHD muscle biopsies correlates with the severity of pathology.

87 A 12-month biopsy cost $13 318/QALY for the base-case cohort.

88 e, where heterogeneous clinical, imaging and biopsy data from diverse sources must be combined to def

89 st should be involved in interpreting liquid biopsy data in the context of the patient's cancer diagn

90 on, peak, and terminal serum creatinine, and biopsy data when available to differentiate kidneys with

91 Evaluation, Imaging, Fine Needle Aspiration Biopsy Diagnosis, Molecular Testing, Indications, Extent

92 Patients who underwent biopsy (endoscopic endonasal vs. open craniotomy) for is

93 tion margin [R] positivity of polypectomy or biopsy), EUS, CT or MRI, and/or (68)Ga-DOTA-TATE PET/CT.

94 suggests insufficient accuracy of endoscopic biopsies, EUS, and 18F-FDG PET(-CT) as single modalities

95 dermal and most immune cells equally well as biopsies, except for mast cells and nonmigratory CD163+

96 R2(TCMR) biopsies expressed typical TCMR-related transcripts, for

97 denoscopies with normal gastric and duodenal biopsies findings and a normal colonoscopy were performe

98 Whether renal biopsy findings add to the clinical assessment in predic

99 from patient stratification based on kidney biopsy findings towards personalized management based on

100 spatial and functional analyses of synovial biopsy fluorescent activated cell sorted STMs, revealed

101 ility as a minimally invasive alternative to biopsies for detecting disease biomarkers.

102 the success rate of (68)Ga-PSMA-guided bone biopsies for molecular diagnostics in mPC patients.

103 R2* relaxation rate can be an alternative to biopsy for assessing LIC.

104 (tubulitis in areas of atrophy) in the first biopsy for cause after 90 days posttransplant (n = 598);

105 were significantly lower than on systematic biopsy for grade group 1 cancers and significantly highe

106 mponents, and ultrastructure) in left atrial biopsies from 121 patients with persistent/long-lasting

107 an independent test dataset comprising 1631 biopsies from 246 men from STHLM3 and an external valida

108 heral blood samples and intestinal allograft biopsies from 51 ITx patients with severe rejection, alo

109 M3 and an external validation dataset of 330 biopsies from 73 men.

110 The role of i-INT was evaluated in 2055 biopsies from 775 renal transplant recipients.

111 Aneuploidy was detected in 49% of liquid biopsies from a total of 883 nonmetastatic, clinically d

112 We studied: (1) 180 liver biopsies from ARLD patients; (2) 20 ARLD explant livers;

113 Serial biopsies from human psoriatic lesions and both the c-Jun

114 that TRPV3 and PAR2 were upregulated in skin biopsies from patients and mice with atopic dermatitis,

115 g macrophages in a human infectious disease, biopsies from patients with leprosy (Hanseniasis) were a

116 DNA (cfDNA) and of matched metastatic tumor biopsies from patients with metastatic prostate adenocar

117 r with cultured Schwann cells (SCs) and skin biopsies from patients with type 2 diabetes (T2DM), we r

118 denosumab (DMAb) and RNA-sequencing of bone biopsies from postmenopausal women to identify osteoclas

119 e cancer patients, where longitudinal tissue biopsies from the bone and other metastatic sites have b

120 monstrated focused ultrasound-enabled liquid biopsy (FUS-LBx) that uses FUS to increase BBB permeabil

121 Perilesional biopsies gave higher positive DIF than lesional biopsies

122 cohort, no significant differences in index biopsy gene expression were identified between BKVN pati

123 A previously identified biopsy gene signature accurately predicted TOL versus no

124 can predict which patients will have a high biopsy Gleason score, a standard pathology score used to

125 77 had rejection diagnosed only on protocol biopsy (>=2R cellular or antibody-mediated), and 45 had

126 However, if only MRI-target biopsies had been performed, 8.8% of clinically signific

127 NETest, a novel multi-gene liquid biopsy has utility in neuroendocrine tumor (NET) diagnos

128 A sensitive liquid biopsy has utility in the management and surveillance of

129 mic pathology program, the advent of "liquid biopsy" has driven a shift in molecular biomarker testin

130 pes, and their biological features in liquid biopsies have generated excitement for their potential a

131 asive methods of diagnosis, including liquid biopsies, have seen major advances as well.

132 the types of tissues found in a nasal septal biopsy, i.e., hyaline cartilage and perichondrium, for a

133 se bulk gene expression data of entire tumor biopsies, ignoring spatial heterogeneity in the TME.

134 IC-related intratumor heterogeneity in PDTX biopsies, improving breast cancer stratification and pot

135 ET/CT may be considered for guidance of bone biopsies in both clinical practice and clinical trials.

136 dy to use cells derived from skeletal muscle biopsies in CFS patients and healthy controls to look at

137 usive results prompted the need for a second biopsy in 18 patients: 13 of 125 (10.4%) in the CT group

138 ress current challenges in the use of liquid biopsy in clinical practice, and consider ways the patho

139 Adding SN biopsy in patients with negative PSMA PET/CT results inc

140 sk for future CAV than rejection on protocol biopsy in pediatric HT recipients.

141 Palatal biopsies, in the form of connective tissue grafts, were

142 fter histopathological reevaluation of these biopsies including additional features of ATI, we develo

143 cken thigh muscle with skin and murine renal biopsy including medulla (M) and cortex (C)) showed dist

144 offers several advantages over conventional biopsies, including better transcriptomic resolution of

145 ffin-embedded sections of naturally infected biopsies indicated that CD20(+) B lymphocytes, CD8(+) T

146 fl)) exhibited impaired mucosal repair after biopsy-induced colonic wounding and recovery from dextra

147 nd Digital breast tomosynthesis (DBT)-guided biopsy is increasingly used in practice.

148 exist to characterize NAFLD and NASH, liver biopsy is the only accepted method for diagnosis of NASH

149 CD163+ macrophages that were only present in biopsy isolates.

150 morphometric electron microscopic studies of biopsied kidney samples from patients and seven living t

151 : Patients undergoing first for cause kidney biopsy (KTxBx) 1.7+/-1.4 (mean +/-SD) years posttranspla

152 Tissue sampling by biopsy may be limited by sampling error, whereas non-inv

153 A total of 2103 men underwent both biopsy methods; cancer was diagnosed in 1312 (62.4%) by

154 ealthy controls in bronchial epithelium from biopsies (n = 27 versus n = 9) and brushings (n = 34 ver

155 evented by (68)Ga-PSMA PET; 73 tests, mostly biopsies (n = 44, 60%) as requested by the study protoco

156 onating LV biopsy (non-pressure-loaded heart biopsy, n=7).

157 A biopsy needle integrated with a multi-modal physical/che

158 Based on these results, we expect that the biopsy needle integrated with the multi-modal sensor arr

159 range, 8-100 months) and were diagnosed with biopsy-negative MMP.

160 n undergoing cardiac surgery and donating LV biopsy (non-pressure-loaded heart biopsy, n=7).

161 ant gene expression pathway is suppressed in biopsies obtained from COVID-19 patients.

162 verall disease upgrade by in-bore MRI-guided biopsy occurred in 40% (16 of 40) of cases (61.5% [16 of

163 Sequencing tumor biopsies of 20 independent patients with MSI colorectal

164 AAT inclusions were detected in liver biopsies of 63% of subjects with the Pi*MZ genotype, vs

165 oxidase-negative cells were found ex vivo in biopsies of affected tissues, such as kidney and skeleta

166 diated apoptosis was replicated in bronchial biopsies of COPD patients.

167 ood mononuclear cells (PBMCs) and skin punch biopsies of IBH lesions and healthy skin from IBH-affect

168 Biopsies of patients with biliary atresia demonstrated i

169 nerves, which were further verified in skin biopsies of patients with T2DM.

170 ent real-time ultrasound-guided percutaneous biopsies of space-occupying liver lesions with the free-

171 ers of the Dlk1-Dio3 miRNA cluster in muscle biopsies of the GRMD dog model.

172 resulting in a positive predictive value for biopsy of 43% (181 true-positive findings of 419 core-ne

173 tic resonance imaging (MRI) and confirmed by biopsy of the temporal artery.

174 emonstrated as useful biomarkers for "liquid biopsy" of the tumor.

175 ficity and sometimes can lead to unnecessary biopsies or even cervical excisions.

176 er for active SARS-CoV-2 infection in kidney biopsy or autopsy specimens.

177 inical or laboratory data or confirmation by biopsy or correlative imaging within 3 mo of PSMA PET.

178 ens in whole mouse organs and embryos, human biopsies, organoids and Drosophila.

179 psies gave higher positive DIF than lesional biopsies (P = .029).

180 iopsies and 71.1% (542 of 762) of DBT-guided biopsies (P = .03).

181 a high number of HER2 gene copies in liquid biopsy (p = 0.04).

182 V1) percentage, positive predictive value of biopsies performed percentage, sensitivity, and specific

183 Most patients had baseline tumor biopsies positive for PD-L1 expression (n = 28/40 evalua

184 to increase the accuracy of the image-guided biopsy process by providing the information of tissue ty

185 ohistochemical staining especially in corpus biopsies proved to be a risk factor for failure of first

186 loss (aHR, 1.68 [1.08-2.62]; P = 0.022) and biopsy-proven acute rejection (aHR, 1.71 [1.13-2.60]; P

187 Biopsy-proven acute rejection (BPAR) rates and types wer

188 ter results for mTORi versus MPA in terms of biopsy-proven acute rejection (hazard ratio [confidence

189 Secondary endpoints were treatment failure (biopsy-proven acute rejection, graft loss, or death), de

190 levels of GDF15 to an increased incidence of biopsy-proven acute rejection.

191 eaths (3 [4.7%] vs 17 [21.9%], P = .007) and biopsy-proven acute rejections (15 [23.4%] vs 31 [48.4%]

192 from those with persisting BKPyV-DNAemia and biopsy-proven BKPyVAN, who would benefit from individual

193 68)Ga-PSMA11) PET/MRI for initial staging of biopsy-proven intermediate- or high-risk PC, and 57 pati

194 posterior left thigh lesion confirmed to be biopsy-proven melanoma.

195 Gut microbiome profiles of 171 Asians with biopsy-proven NAFLD and 31 non-NAFLD controls are analyz

196 e sequencing was performed in a cohort of 83 biopsy-proven NAFLD patients and 13 patients with non-in

197 Our aims were to determine whether biopsy-proven NASH impacts clinical outcomes in CHB pati

198 ve study of 180 severely obese patients with biopsy-proven NASH, defined by the NASH clinical researc

199 ur patients (46% men) with single, sporadic, biopsy-proven RCC (median size +/- standard deviation, 2

200 an lead time between ctHPVDNA positivity and biopsy-proven recurrence was 3.9 months (range, 0.37-12.

201 cardiac allograft recipients at the time of biopsy-proven rejection.

202 Tumor recurrence was defined as biopsy-proven vital tumor at the initial tumor site.

203 edian ADC provided the greatest reduction in biopsy rate of 23.9% (95% CI: 14.8, 32.9; 16 of 67 BI-RA

204 c molecular expression patterns in allograft biopsies related to different types of allograft injury

205 ify the presence of rejection, endoscopy and biopsy remain the gold standard for its diagnosis.

206 ation to an independent series of diagnostic biopsies replicated the subgroups, with immune cell comp

207 Sequencing data from a single biopsy represent a snapshot of this process that can rev

208 tologic activity index <=1 or >1 in repeated biopsies, respectively.

209 HSIL recurrence was associated with a LEEP biopsy result of HSIL and detection of HSIL at the margi

210 R and delays <4 weeks in patients with a STR/biopsy resulted in worse survival.

211 Of the 292, 27 patients underwent subsequent biopsies, results of which were negative for cancer; one

212 mination of tissue sample from colonic ulcer biopsy revealed invasive intestinal mucormycosis.

213 n-alcoholic steatohepatitis and cirrhosis in biopsied samples of human liver tissue.

214 a mouthwash, and discriminate between fresh biopsied samples of the oral tumour and the surgical res

215 Blubber biopsy samples (n = 185) of female humpback whales were

216 o detect and grade cancer in prostate needle biopsy samples at a ranking comparable to that of intern

217 sease activity was evaluated in 2630 colonic biopsy samples from patients with UC treated in the UNIF

218 lonogenic cells from 1-mm-diamter endoscopic biopsy samples from the human gastrointestinal tract.

219 ion of the cell populations present in small biopsy samples of kidney tissue.

220 testinal defects, and colonoids derived from biopsy samples of patients with and without mutations in

221 led, time course SLIT study, PBMCs and nasal biopsy samples were collected from 40 adults with season

222 Biopsy samples were histologically graded as CIN2+ or <C

223 der-collected cervical samples, and cervical biopsy samples were obtained from all enrolled women.

224 d protease activity in human prostate cancer biopsy samples, enabling disease classification.

225 Liver biopsy samples, NIT results, and PROs (Short Form-36, Ch

226 showed no evidence of viral particles in the biopsy samples.

227 activity from human-derived liver samples in biopsy-scale.

228 the likelihood of finding MGRS, and a kidney biopsy should be highly considered in such patients.

229 Extraocular muscle biopsy should be strongly considered whenever the presen

230 Muscle biopsies showed complete loss of large supervillin isofo

231 omical voltage mapping-guided endomyocardial biopsy showed low endocardial voltages and fibro-fatty r

232 Muscle biopsy shows rods and fiber type disproportion.

233 ation and gene expression profile at the DTH biopsy site corresponds to immunosuppression of an Ag-in

234 ta2-GPI was observed on the endothelium of a biopsy specimen of a femoral artery from an APS patient.

235 Skin biopsy specimens and blood samples were collected on day

236 Tumor biopsy specimens from 5,954 patients with refractory mal

237 We conducted a study of blood and skin biopsy specimens from 57 patients with a clinical diagno

238 s robust on cytologic analysis and open-flap biopsy specimens of ciliary epithelial and iris epitheli

239 Muscle biopsy specimens were obtained at baseline and 3 and 9 m

240 All biopsy specimens with crescentic GN had extracellular gl

241 stitium was performed on 30 for-cause kidney biopsy specimens with early AMR, acute cellular rejectio

242 degree of steatosis was evaluated from liver biopsy specimens.

243 h CKD progression in animal models and human biopsy specimens.

244 ls, kidney ultrasound imaging, and digitized biopsy specimens.

245 d hepatocytes and chronic HCV-infected liver biopsy specimens.

246 her, cancer detection stratified by previous biopsy status, and grade reclassification between biopsy

247 pathophysiology is largely derived from skin biopsy studies that cause scarring and may be impractica

248 Despite whole tissue biopsy studies that have advanced the mechanistic unders

249 undifferentiated gastric carcinoma from the biopsy taken from the ulcerated lesion on the stomach ca

250 Biopsies, taken on day 10 and after a 5-day observationa

251 Calcifications were the most common biopsy target for both groups, constituting 89.9% (578 o

252 hemical analyses of tissue from a lymph node biopsy; the tissue morphology and antigen expression pro

253 t of 17 patients with prospectively targeted biopsies there was a positive linear correlation between

254 Of these indication biopsies, those with i-IFTA >= 2, without meeting other

255 ATN, milder i-INT, and early posttransplant biopsy times.

256 d on formalin fixed paraffin embedded kidney biopsy tissue, using mass spectrometry (HPLC-MS/MS) (n =

257 ted genes within sub-populations of blood or biopsied tissues.

258 mic clinical trial interventions with liquid biopsies to deliver precision medicine.

259 is work used shotgun metagenomics of mucosal biopsies to explore the microbial communities' compositi

260 urn requires upper endoscopy with esophageal biopsies to rule out anatomic and mucosal abnormalities,

261 e cTAG score for screening patients prior to biopsy to identify those suitable for NASH clinical tria

262 models to assess associations with time from biopsy to proteinuria remission and time to a composite

263 h we have previously presented as a chemical biopsy tool for use during in vivo lung perfusion (IVLP)

264 ffin-embedded lung biopsies with normal lung biopsies, using immunostaining, RNA sequencing, and RT-P

265 in a renal transplant program with protocol biopsies was used to establish multivariable models for

266 detection rate when using in-bore MRI-guided biopsy was 65% (26 of 40).

267 t subsequent radical prostatectomy, combined biopsy was associated with the fewest upgrades to grade

268 Screening with protocol biopsy was favored over biomarkers.

269 In 61.4%, the biopsy was indicated for the initial diagnosis; 82.4% of

270 Biopsy was performed with stereotactic guidance in 29 st

271 nes, nuclei from frozen prostate tumors, and biopsy washes.

272 ipated in a mechanistic substudy where punch biopsies were collected (lesional and nonlesional skin)

273 During the periodontal surgery gingival biopsies were collected and processed for histo-morphome

274 Adipose tissue biopsies were collected from 13 adult female polar bears

275 Subgingival plaque samples and gingival biopsies were collected from healthy sites and at sites

276 ndicated for the initial diagnosis; 82.4% of biopsies were done in hospitalized patients, and 65% of

277 Bone marrow biopsies were obtained 14-24 h after infusion, and the p

278 Ectocervical biopsies were obtained for quantification of TFV-DP and

279 Limbal biopsies were obtained from the contralateral eye and th

280 vents, laboratory results, imaging and liver biopsies were retrospectively collected.

281 Human bronchial biopsies were stained for cholinergic marker vesicular a

282 Nasal biopsies were taken 24 hours after the 1st and 5th chall

283 munological players and pathways, human skin biopsies were taken at 0, 2, 48, and 96 hours after nick

284 For validation, lung wedge biopsies were taken from nonobstructed and obstructed lu

285 d clinical borderline rejections in protocol biopsies were treated.

286 transbronchial lung biopsy and surgical lung biopsy were also made.

287 The most common indications for biopsy were nonresolving orbital disease with inadequate

288 with granuloma or moderate-severe ileitis on biopsy were significantly associated with Crohn's develo

289 Cancer detection rates on MRI-targeted biopsy were significantly lower than on systematic biops

290 onsense DMD mutations, with available muscle biopsy Western blot data, were included irrespective of

291 nt underwent wide excision and sentinel node biopsy, which showed absence of residual melanoma.

292 dentified by histological analysis on muscle biopsies, while our two late DUX4 target gene expression

293 We were able to perform CT-guided biopsies with histologic validation of the nonresponding

294 s; (2) 20 ARLD explant livers; (3) 213 liver biopsies with non-ARLD injury.

295 ned and compared EGPA paraffin-embedded lung biopsies with normal lung biopsies, using immunostaining

296 SMA PET/CT were considered candidates for SN biopsy with indocyanine green-(99m)Tc-nanocolloid or (99

297 +) T cells directly isolated from intestinal biopsies, with gammac cytokines in presence or absence o

298 Biopsies without supporting clinical history or tissue a

299 ent data suggest that frequent endoscopy and biopsy without evidence of graft dysfunction does not ap

300 Compared to biomarkers, protocol biopsy yielded more quality-adjusted life years (QALYs)